While this study has several strengths in that we have linked decreased NSun2 expression to tau pathology and neurodegeneration in various in vitro and in vivo models including mice, flies, primary cultures, human iPSC-derived neurons, and AD patient brains, we recognize that there are also some limitations. This evidence concerns the gene MAPT and Alzheimer disease.